Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

Name: Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study
License: Public Domain

Regeneron Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

retinal vasculitis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208340
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.